| Literature DB >> 31574122 |
Shan Jiang1,2, Fuqiang Li1,2, Xiuli Li1,2, Lili Wang1,2, Li Zhang1,2, Chao Lu1,2, Li Zheng1,2, Minghua Yan1,2.
Abstract
Porcine deltacoronavirus (PDCoV) is a newly emerged swine enteropathogenic coronavirus affecting pigs of all ages and causing diarrhea problems. Research findings indicate that PDCoV has evolved strategies to escape innate immune response in host cells, but mechanism of PDCoV in innate immune modulation is not well understood. In this study, we report our findings on identifying the alterations of host cell innate immune response affected by PDCoV infection and exploring the gene expression profiles of PK-15 cells at 0, 24, and 36 h PDCoV post infection by RNA sequencing. A total of 3,762 and 560 differentially expressed genes (DEGs) were screened by comparison of uninfected PK-15 cells and infected PK-15 cells at 24 h post infection (hpi) (INF_24h versus NC), and also comparison of infected PK-15 cells between 24 and 36 hpi (INF_36h versus INF_24h), which included 156 and 23 porcine innate immune-related genes in the DEGs of INF_24h versus NC and INF_36h versus INF_24h, respectively. Gene Ontology function classification and Kyoto Encyclopedia of Genes and Genomes signaling pathway enrichment analysis were performed based on the DEGs that exhibited the same expression tendencies with most of the innate immune-associated genes among these PK-15 cell samples described above. The enrichment results indicated that extensive gene functions and signaling pathways including innate immune-associated functions and pathways were affected by PDCoV infection. Particularly, 4 of 5 innate immune signaling pathways, which were primarily affected by PDCoV, played important roles in I-IFN's antiviral function in innate immune response. Additionally, 16 of the host cell endogenous miRNAs were predicted as potential contributors to the modulation of innate immune response affected by PDCoV. Our research findings indicated that the innate immune-associated genes and signaling pathways in PK-15 cells could be modified by the infection of PDCoV, which provides a fundamental foundation for further studies to better understand the mechanism of PDCoV infections, so as to effectively control and prevent PDCoV-induced swine diarrheal disease outbreaks.Entities:
Year: 2019 PMID: 31574122 PMCID: PMC6773216 DOI: 10.1371/journal.pone.0223177
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Cytopathic effect of PK-15 cell infections by PDCoV at 0, 24 and 36 hpi.
In comparison with normal PK-15 cells (A), PDCoV infected cells at 24 hpi (B) exhibited CPE of rounded cells (arrow), shrinkaged cells and released cells from monolyer; after prolonged to 36 hpi, PDCoV infected showed more progressive development of CPEs (C).
Fig 2IFA staining on PK-15 cells.
IFA stained positive (green fluorescence) on PDCoV-infected PK-15 cells (A) and negative on normal PK-15 cells (B).
Statistics of RNA sequencing results.
| Sample | Raw reads | Clean reads | Clean bases (G) | Sequencing error rate (%) | Q20 (%) | Q30 (%) | GC content (%) | Total mapping rate (%) | Unique mapping rate (%) | Expressed genes | Novel genes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NC_1 | 26,873,398 | 26,397,492 | 7.92 | 0.03 | 97.18 | 92.50 | 53.06 | 95.18 | 92.56 | 21516 | 5591 |
| NC_2 | 24,489,789 | 23,998,778 | 7.20 | 0.03 | 97.19 | 92.54 | 52.94 | 94.80 | 92.25 | 20813 | 5386 |
| INF_24h1 | 29,972,480 | 29,121,085 | 8.74 | 0.03 | 97.46 | 93.44 | 53.61 | 94.10 | 91.20 | 22169 | 6160 |
| INF_24h2 | 25,687,216 | 24,943,590 | 7.48 | 0.03 | 97.58 | 93.73 | 53.85 | 94.39 | 91.53 | 21425 | 5998 |
| INF_36h1 | 29,874,857 | 28,998,514 | 8.70 | 0.03 | 97.60 | 93.72 | 54.20 | 94.32 | 91.54 | 21349 | 6097 |
| INF_36h2 | 23,435,580 | 22,780,078 | 6.83 | 0.03 | 97.16 | 92.53 | 53.56 | 94.50 | 91.71 | 21224 | 6012 |
Fig 3DEGs in INF_24 h versus NC and INF_36 h versus INF_24 h.
(A): DEGs upregulated and downregulated on PK-15 cells at 24 hpi represented by red dots, uninfected PK-15 cells represented by green dots. Genes with no significant differences in expression represented in blue. (B): DEGs upregulated in INF_36 h compared to INF_24 h, the same color coded dots as (A).
Fig 4Innate immune-associated DEG.
Innate immune-associated genes of DEGs in INF_24h versus NC (A) and INF_36h versus INF_24h (B) were illustrated in heatmaps that were created based on the expression of each DEG. (A) Genes with upregulated tendencies in INF_24h comparing to NC were displayed in red while genes with downregulated tendencies in INF_24h comparing to NC were shown in blue. (B) Genes with upregulated tendencies in INF_36h comparing to INF_24h were represented in red while genes with downregulated tendencies were shown in blue.
Fig 5Common genes belonging to DEGs in INF_24h versus NC and INF_36h versus INF_24h.
(A) A total of 400 DEGs were commonly expressed in the 2 comparison groups. (B) Innate immune-associated genes of DEGs commonly shared in cells at 0, 24, and 36 hpi were illustrated in a heatmap. The heatmap was constructed based on the expression for each DEG with 2 replicates examined.
Fig 6Relative expression of 5 randomly selected genes among PK-15 cells at 0, 24 and 36 hpi.
Relative expression of all of the genes were coincident with our RNA sequencing results. Data are displayed as mean ± SD (n = 2); *p < 0.05; **p < 0.01; ***p < 0.001.
Fig 7Gene function classifications of DEGs in 2 comparison groups.
Gene function classifications of DEGs in INF_24h versus NC and INF_36h versus INF_24h comparisons are represented by blue and red bars, respectively.
Fig 8GO function enrichment results of DEGs in 2 comparison groups.
Top 10 significantly enriched GO terms of each category, including biological process (BP), cellular component (CC), and molecular function (MF) were displayed in this figure (A: INF_24h versus NC; B: INF_36h versus INF_24h). Enriched GO terms with p < 0.05 were considered to be statistically significant.
GO function enrichment results of upregulated DEGs in cells at 24 hpi comparing to unfected cells.
| Category | ID | Description | Gene name | Count | |
|---|---|---|---|---|---|
| BP | GO:0002252 | Immune effector process | 1.47E-05 | 15 | |
| BP | GO:0002376 | Immune system process | 2.42E-05 | 31 | |
| BP | GO:0006955 | Immune response | 8.04E-05 | 25 | |
| BP | GO:0001819 | Positive regulation of cytokine production | 1.45E-03 | 8 | |
| BP | GO:0045087 | Innate immune response | 1.70E-03 | 13 | |
| BP | GO:0032635 | Interleukin-6 production | 2.99E-03 | 5 | |
| BP | GO:0001817 | Regulation of cytokine production | 4.50E-03 | 10 | |
| BP | GO:0042035 | Regulation of cytokine biosynthetic process | 4.97E-03 | 5 | |
| BP | GO:0042089 | Cytokine biosynthetic process | 7.74E-03 | 5 | |
| BP | GO:0042107 | Cytokine metabolic process | 7.74E-03 | 5 | |
| BP | GO:0001816 | Cytokine production | 1.24E-02 | 10 | |
| BP | GO:0002758 | Innate immune response-activating signal transduction | 2.05E-02 | 4 | |
| BP | GO:0002218 | Activation of innate immune response | 2.93E-02 | 4 | |
| BP | GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 2.93E-02 | 4 | |
| BP | GO:0045089 | Positive regulation of innate immune response | 2.93E-02 | 4 | |
| BP | GO:0002682 | Regulation of immune system process | 2.99E-02 | 13 | |
| BP | GO:0002757 | Immune response-activating signal transduction | 3.74E-02 | 5 | |
| BP | GO:0002697 | Regulation of immune effector process | 4.71E-02 | 5 | |
| MF | GO:0005126 | Cytokine receptor binding | 9.74E-04 | 13 | |
| MF | GO:0005125 | Cytokine activity | 1.86E-02 | 10 |
Immune and innate immune response-related GO terms were represented in this table.
GO function enrichment results of downregulated DEGs in cells at 36 hpi comparing to cells at 24 hpi.
| Category | ID | Description | Gene name | Count | |
|---|---|---|---|---|---|
| BP | GO:0002376 | Immune system process | 1.69E-02 | 7 | |
| BP | GO:0006955 | Immune response | 1.87E-02 | 6 | |
| BP | GO:0042035 | Regulation of cytokine biosynthetic process | 2.19E-02 | 2 | |
| BP | GO:0042089 | Cytokine biosynthetic process | 2.59E-02 | 2 | |
| BP | GO:0042107 | Cytokine metabolic process | 2.59E-02 | 2 | |
| BP | GO:0001817 | Regulation of cytokine production | 3.74E-02 | 3 | |
| MF | GO:0005125 | Cytokine activity | 2.78E-03 | 5 | |
| MF | GO:0005126 | Cytokine receptor binding | 3.50E-03 | 5 |
Immune and innate immune response-related GO terms were represented in this table.
Fig 9KEGG pathway enrichment results of DEGs in 2 comparison groups.
KEGG signaling pathways which were significantly enriched in INF_24h versus NC and INF_36h versus INF_24h are represented in (A) and (B), respectively. Enriched signaling pathways with p < 0.05 were considered to be statistically significant.
KEGG pathway enrichment results of upregulated DEGs in INF_24h comparing to NC.
| ID | Description | Gene ratio | Gene name | Count | |
|---|---|---|---|---|---|
| ssc04060 | Cytokine-cytokine receptor interaction | 27/434 | 3.46E-04 | 27 | |
| ssc04621 | NOD-like receptor signaling pathway | 21/434 | 1.01E-03 | 21 | |
| ssc04064 | NF-kappa B signaling pathway | 13/434 | 1.76E-03 | 13 | |
| ssc04622 | RIG-I-like receptor signaling pathway | 11/434 | 4.75E-03 | 11 | |
| ssc04630 | Jak-STAT signaling pathway | 19/434 | 6.74E-03 | 19 | |
| ssc04623 | Cytosolic DNA-sensing pathway | 8/434 | 2.43E-02 | 8 |
Innate immune response-related pathways were represented in this table.
KEGG pathway enrichment results of downregulated DEGs in INF_36h comparing to INF_24h.
| ID | Description | Gene ratio | Gene name | Count | |
|---|---|---|---|---|---|
| ssc04620 | Toll-like receptor signaling pathway | 8/75 | 1.77E-05 | 8 | |
| ssc04623 | Cytosolic DNA-sensing pathway | 5/75 | 3.28E-04 | 5 | |
| ssc04060 | Cytokine-cytokine receptor interaction | 8/75 | 2.53E-03 | 8 | |
| ssc04151 | PI3K-Akt signaling pathway | 10/75 | 4.74E-03 | 10 | |
| ssc04622 | RIG-I-like receptor signaling pathway | 4/75 | 7.52E-03 | 4 | |
| ssc04015 | Rap1 signaling pathway | 7/75 | 9.37E-03 | 7 | |
| ssc04630 | Jak-STAT signaling pathway | 5/75 | 3.14E-02 | 5 | |
| ssc04621 | NOD-like receptor signaling pathway | 5/75 | 3.35E-02 | 5 | |
| ssc04014 | Ras signaling pathway | 6/75 | 4.82E-02 | 6 |
Innate immune response-related pathways were represented in this table.
Predicted miRNAs with unique targets.
| Species | MiRNA | Target gene | Innate immune signaling pathway |
|---|---|---|---|
| miR-195 | NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, | ||
| miR-7137-3p | NOD-like receptor signaling pathway | ||
| miR-4334-5p | NOD-like receptor signaling pathway | ||
| miR-139-3p | NOD-like receptor signaling pathway | ||
| miR-493-3p | NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, | ||
| miR-9822-3p | NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway | ||
| let-7a | Jak-STAT signaling pathway | ||
| miR-4335 | NOD-like receptor signaling pathway | ||
| miR-1306-5p | RIG-I-like receptor signaling pathway | ||
| miR-9853-5p | Jak-STAT signaling pathway | ||
| miR-92b-5p | NOD-like receptor signaling pathway | ||
| miR-671-5p | RIG-I-like receptor signaling pathway |
Predicted miRNAs with multiple targets.
| Species | MiRNA | Target gene | Innate immune signaling pathway |
|---|---|---|---|
| miR-17-3p | NOD-like receptor signaling pathway | ||
| NOD-like receptor signaling pathway, Jak-STAT signaling pathway | |||
| miR-328 | NOD-like receptor signaling pathway | ||
| RIG-I-like receptor signaling pathway | |||
| miR-874 | Jak-STAT signaling pathway | ||
| NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, | |||
| Jak-STAT signaling pathway | |||
| miR-370 | Jak-STAT signaling pathway | ||
| Jak-STAT signaling pathway | |||
| NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, | |||
| NOD-like receptor signaling pathway |
Fig 10Binding sites between miRNAs and their target genes covered in innate immune signaling pathways.
Four miRNAs with multiple targets were selected to display the binding sites (A: miR-17-3p; B: miR-328; C: miR-874; D: miR-370). The results of binding sites were predicted by RNAhybrid. The binding sites with a minimum free energy (MFE) < −10 kcal/mol and a p-value < 0.05 were considered to be stable binding site structures.